Inventor · disambiguated record
Roberto Meidler
Also filed as: MEIDLER ROBERTO
16 granted patents·4 pending applications·25 citations·filing 2006–2024
89Inventor score
Files withOMRIX BIOPHARMACEUTICALS LTD12ATLAS ROEE1BUENSUCESO CHARITO S1DE ANGLIS ASHLEY1DEPUY SYNTHES PRODUCTS INC1
Top patents by PatentIndex Score
20 records- 0187US2024376459A1Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0284US9125906B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsBUENSUCESO CHARITO S·Filed 2011·Granted Sep 8, 2015·9 cites·28 claims
- 0383US9585918B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsDEPUY SYNTHES PRODUCTS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
- 0482US9439997B2Reinforced absorbable multilayered hemostatis wound dressingGORMAN ANNE JESSICA·Filed 2006·Granted Sep 13, 2016·4 cites·9 claims
- 0576US9328338B2Method for removing a lytic enzyme from a heterogeneous mixtureMEIDLER ROBERTO·Filed 2012·Granted May 3, 2016·5 cites·15 claims
- 0673US11993797B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 0769US12203947B2Device and process for sample preparationOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jan 21, 2025·0 cites·10 claims
- 0869US11225652B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Jan 18, 2022·0 cites·12 claims
- 0969US9023994B2Immunoglobulin reduced in thrombogenic agents and preparation thereofMINTZ RONI·Filed 2012·Granted May 5, 2015·2 cites·14 claims
- 1066US11009513B2Device and process for sample preparationOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted May 18, 2021·0 cites·4 claims
- 1166US9213035B2Protein assayDE ANGLIS ASHLEY·Filed 2008·Granted Dec 15, 2015·3 cites·25 claims
- 1265US9212357B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 1364US10479987B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Nov 19, 2019·0 cites·9 claims
- 1460US9896716B2Protein assayOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Feb 20, 2018·0 cites·3 claims
- 1558US10466258B2Device and process for sample preparationOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Granted Nov 5, 2019·0 cites·14 claims
- 1657US2010203033A1Kits, formulations and solutions having enzymatically- permissive amounts of visualization agents and uses thereofNUR ISRAEL·Filed 2008·Application pending·0 cites
- 1749US2018093010A1Kits, formulations and solutions having enzymatically- permissive amounts of visualization agents and uses thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 1845US9796770B2Immunoglobulin reduced in thrombogenic agents and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Oct 24, 2017·0 cites·22 claims
- 1938US2012039855A1Fibrin based scaffold, preparation and use thereofATLAS ROEE·Filed 2011·Application pending·0 cites
- 2036US10806755B2Plasma-supplemented formulationOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Oct 20, 2020·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Roberto Meidler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →